Sigurdis Haraldsdottir
Sigurdis Haraldsdottir
Verified email at
Cited by
Cited by
Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations
S Haraldsdottir, H Hampel, J Tomsic, WL Frankel, R Pearlman, ...
Gastroenterology 147 (6), 1308-1316. e1, 2014
NCCN guidelines insights: genetic/familial high-risk assessment: colorectal, version 2.2019: featured updates to the NCCN guidelines
S Gupta, D Provenzale, X Llor, AL Halverson, W Grady, DC Chung, ...
Journal of the National Comprehensive Cancer Network 17 (9), 1032-1041, 2019
Colorectal cancer-review
S Haraldsdottir, HM Einarsdottir, A Smaradottir, A Gunnlaugsson, ...
Laeknabladid 100 (2), 75-82, 2014
Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2
S Haraldsdottir, T Rafnar, WL Frankel, S Einarsdottir, A Sigurdsson, ...
Nature communications 8 (1), 14755, 2017
Prostate cancer incidence in males with Lynch syndrome
S Haraldsdottir, H Hampel, L Wei, C Wu, W Frankel, T Bekaii-Saab, ...
Genetics in medicine 16 (7), 553-557, 2014
Anti-proliferative effects of lichen-derived lipoxygenase inhibitors on twelve human cancer cell lines of different tissue origin in vitro
S Haraldsdóttir, E Guðlaugsdóttir, K Ingólfsdóttir, HM Ögmundsdóttir
Planta medica 70 (11), 1098-1100, 2004
Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome
R Pearlman, S Haraldsdottir, A De La Chapelle, JG Jonasson, ...
Journal of medical genetics 56 (7), 462-470, 2019
Effects of tenuiorin and methyl orsellinate from the lichen Peltigera leucophlebia on 5-/15-lipoxygenases and proliferation of malignant cell lines in vitro
K Ingólfsdóttir, GF Gudmundsdóttir, HM Ögmundsdóttir, K Paulus, ...
Phytomedicine 9 (7), 654-658, 2002
Management of borderline resectable pancreatic cancer
DAS Toesca, AJ Koong, GA Poultsides, BC Visser, S Haraldsdottir, ...
International Journal of Radiation Oncology* Biology* Physics 100 (5), 1155-1174, 2018
Promising new agents for colorectal cancer
S Das, KK Ciombor, S Haraldsdottir, RM Goldberg
Current treatment options in oncology 19, 1-14, 2018
Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses
S Haraldsdottir, H Hampel, C Wu, DY Weng, PG Shields, WL Frankel, ...
Genetics in medicine 18 (9), 863-868, 2016
Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasis
S Haraldsdottir, R Roth, R Pearlman, H Hampel, CA Arnold, WL Frankel
Familial Cancer 15, 253-260, 2016
Diagnostic accuracy of 64-slice multidetector CT for detection of in-stent restenosis in an unselected, consecutive patient population
S Haraldsdottir, T Gudnason, AF Sigurdsson, J Gudjonsdottir, SJ Lehman, ...
European journal of radiology 76 (2), 188-194, 2010
Phase 2 trial of the IDO pathway inhibitor indoximod plus gemcitabine/nab-paclitaxel for the treatment of patients with metastatic pancreas cancer.
N Bahary, A Wang-Gillam, S Haraldsdottir, BG Somer, JS Lee, ...
Journal of Clinical Oncology 36 (15_suppl), 4015-4015, 2018
Frequent PIK3CA mutations in colorectal and endometrial tumors with 2 or more somatic mutations in mismatch repair genes
SA Cohen, EH Turner, MB Beightol, A Jacobson, TA Gooley, SJ Salipante, ...
Gastroenterology 151 (3), 440-447. e1, 2016
An update on clinical trials of targeted therapies in thyroid cancer
S Haraldsdottir, MH Shah
Oncology in Clinical Practice 10 (2), 121-130, 2014
Histology of colorectal adenocarcinoma with double somatic mismatch-repair mutations is indistinguishable from those caused by Lynch syndrome
JA Hemminger, R Pearlman, S Haraldsdottir, D Knight, JG Jonasson, ...
Human pathology 78, 125-130, 2018
Integrating anti-EGFR therapies in metastatic colorectal cancer
S Haraldsdottir, T Bekaii-Saab
Journal of gastrointestinal oncology 4 (3), 285, 2013
Microsatellite instability and adjuvant chemotherapy in stage II colon cancer
JL Koenig, DAS Toesca, JP Harris, CJ Tsai, S Haraldsdottir, AY Lin, ...
American Journal of Clinical Oncology 42 (7), 573-580, 2019
Targeting BRAF mutations in high-grade neuroendocrine carcinoma of the colon
J Burkart, D Owen, MH Shah, SRZ Abdel-Misih, S Roychowdhury, ...
Journal of the National Comprehensive Cancer Network 16 (9), 1035-1040, 2018
The system can't perform the operation now. Try again later.
Articles 1–20